Immunomodulatory antibodies for the treatment of lymphoma: Report on the CALYM Workshop

Roch Houot, Philippe Gaulard, Robert Schreiber, Ira Mellman, Olivier Lambotte, Pierre G. Coulie, Thierry Fest, Alan Korman, Ronald Levy, Margaret Shipp, Karin Tarte, Holbrook Kohrt, Aurélien Marabelle, Stephen Ansell, Hervé Watier, Andrea van Elsas, Arun Balakumaran, Frederick Arce Vargas, Sergio A. Quezada, Gilles SallesDaniel Olive

Research output: Contribution to journalArticlepeer-review

2 Scopus citations


In November 2015, the CALYM Carnot Institute held a 2-d workshop to discuss the current and future development of immunomodulatory antibodies for the treatment of lymphoma. Highlights from the workshop are presented in this article.

Original languageEnglish (US)
Article numbere1186323
Issue number7
StatePublished - Jul 2 2016


  • Immunomodulation
  • immunotherapy
  • lymphoma
  • programmed cell death 1 ligand 1
  • programmed cell death 1 receptor

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Oncology


Dive into the research topics of 'Immunomodulatory antibodies for the treatment of lymphoma: Report on the CALYM Workshop'. Together they form a unique fingerprint.

Cite this